1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Colombia Pharmaceuticals and Healthcare Report Q4 2015

Colombia Pharmaceuticals and Healthcare Report Q4 2015

  • August 2015
  • -
  • Business Monitor International
  • -
  • 116 pages

Includes 3 FREE quarterly updates

BMI View: A growing burden of chronic diseases, along with the Colombian government's push toward
improving its national healthcare system will ensure the country's retained appeal to multinational drugmakers and healthcare suppliers. Despite remaining concerns surrounding Colombia's counterfeit drug market, the country's overwhelming demand for medical access will keep health and medicine spending on a positive trajectory over the long term.

Headline Expenditure Projections

- Pharmaceuticals: COP8,643bn (USD4.3bn) in 2014 to COP9,110bn (USD3.6bn) in 2015; +5.4% in local currency terms. Forecast revised upward from Q215 due to historical data.
- Healthcare: COP53,417bn (USD26.7bn) in 2014 to COP57,414bn (USD22.4bn) in 2015; +7.5% in local currency terms. Forecast revised upward from Q215 due to historical data.

Table Of Contents

Colombia Pharmaceuticals and Healthcare Report Q4 2015
BMI Industry View 7
SWOT 9
Political 11
Economic 12
Operational Risk 13
Industry Forecast 15
Pharmaceutical Market Forecast 15
Table: Pharmaceutical Sales, Historical Data And Forecasts (Colombia 2011-2019) 17
Healthcare Market Forecast 18
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Colombia 2011-2019) 20
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Colombia 2011-2019) 21
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Colombia 2011-2019) 22
Prescription Drug Market Forecast 23
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Colombia 2011-2019) 24
Patented Drug Market Forecast 25
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Colombia 2011-2019) 27
Generic Drug Market Forecast 28
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Colombia 2011-2019) 30
OTC Medicine Market Forecast 31
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Colombia 2011-2019) 33
Pharmaceutical Trade Forecast 34
Table: Pharmaceutical Trade Data And Forecasts (Colombia 2013-2019) 36
Table: Pharmaceutical Trade Data And Forecasts local currency (Colombia 2013-2019) 36
Key Risks To BMI's Forecast Scenario 37
Macroeconomic Forecasts 38
Economic Analysis 38
Table: Colombia - Key Economic Indicators 38
Table: Colombia - Private Consumption Forecasts 41
Table: Colombia - Government Consumption Forecasts 42
Table: Colombia - Fixed Investment Forecasts 43
Table: Colombia - Net Exports Forecasts 43
Industry Risk Reward Indices 44
Americas Risk/Reward Index - Q4 2015 44
Colombia Risk/Reward Index 50
Rewards 50
Risks 51
Market Overview 52
Industry Trends And Developments 54
Epidemiology 54
Healthcare Sector 56
Table: Healthcare Resources (Colombia 2009-2014) 59
Table: Healthcare Personnel (Colombia 2009-2014) 59
Table: Healthcare Activity (Colombia 2009-2014) 60
Research And Development 60
Table: Pharmaceutical Research and Science Centre (CECIF) Members, 2015 61
Clinical Trials 61
Regulatory Development 63
Intellectual Property Regime 64
Table: Colombia-US FTA Mechanisms Relevant To Intellectual Property 67
Pricing Regime 67
Reimbursement Regime 69
Competitive Landscape 72
Research-Based Industry 72
Table: Members Of Asociación De Laboratorios Farmaceuticos De Investigación (AFIDRO), 2012 73
Table: Leading Pharmaceutical Companies By Revenues, 2011 (COPmn) 74
Pharmaceutical Distribution 75
Table: Leading Pharmaceutical Importers/Wholesalers By Revenues, 2011 75
Pharmaceutical Retail 76
Company Profile 78
GlaxoSmithKline 78
Laboratorios Bussie 81
Laboratorios Genfar SA 84
Lafrancol 87
Merck and Co 90
Novartis 93
Pfizer 96
Sanofi 99
Tecnoquímicas 102
Demographic Forecast 105
Table: Population Headline Indicators (Colombia 1990-2025) 106
Table: Key Population Ratios (Colombia 1990-2025) 106
Table: Urban/Rural Population and Life Expectancy (Colombia 1990-2025) 107
Table: Population By Age Group (Colombia 1990-2025) 107
Table: Population By Age Group % (Colombia 1990-2025) 108
Glossary 110
Methodology 112
Pharmaceutical Expenditure Forecast Model 112
Healthcare Expenditure Forecast Model 112
Notes On Methodology 113
Risk/Reward Index Methodology 114
Index Overview 115
Table: Pharmaceutical Risk/Reward Index Indicators 115
Indicator Weightings 116

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.